SPC
BNTX icon

Sigma Planning Corp’s BioNTech BNTX Stock Holding History

Sigma Planning Corp’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-816
Closed -$210K – 1379
2021
Q4 		$210K Sell
816
-129
-14% -$35.3K 0.01% 1262
2021
Q3 		$258K Sell
945
-190
-17% -$60.4K 0.01% 1142
2021
Q2 		$254K Buy
+1,135
New +$214K 0.01% 1176

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sigma Planning Corp's BNTX Position: Q1 2022 in Review

Sigma Planning Corp sold out of BioNTech (BNTX) in Q1 2022, closing a stake of 816 shares — an estimated $210K sold.

Sigma Planning Corp first reported a position in BNTX in Q2 2021 and held it in 3 quarters. The position peaked at $258K in Q3 2021. 287 funds tracked by Wall St. Rank hold BNTX as of Q1 2022.

  • Sigma Planning Corp reported no remaining BioNTech position as of Q1 2022 after selling out during the quarter.
  • Sigma Planning Corp sold 816 BioNTech shares in Q1 2022, an estimated $210K.
  • Sigma Planning Corp first reported a position in BioNTech in Q2 2021 and held it in 3 quarters.
  • Sigma Planning Corp's BioNTech position peaked at $258K in Q3 2021.
  • 287 funds tracked by Wall St. Rank held BioNTech as of Q1 2022.

Based on Sigma Planning Corp's 13F filing for Q1 2022, filed 20 Apr 2022.